Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 8;16(6):1435-1445.
doi: 10.1016/j.stemcr.2021.05.004.

Unproven stem cell interventions: A global public health problem requiring global deliberation

Affiliations
Review

Unproven stem cell interventions: A global public health problem requiring global deliberation

Zubin Master et al. Stem Cell Reports. .

Abstract

The unproven stem cell intervention (SCI) industry is a global health problem. Despite efforts of some nations, the industry continues to flourish. In this paper, we call for a global approach and the establishment of a World Health Organization (WHO) Expert Advisory Committee on Regenerative Medicine to tackle this issue and provide guidance. The WHO committee can harmonize national regulations; promote regulatory approaches responsive to unmet patient needs; and formulate an education campaign against misinformation. Fostering an international dialog and developing recommendations that can be adopted by member states would effectively address the global market of unproven SCIs.

Keywords: World Health Organization; global health; patient views; regenerative medicine; regulations; unproven stem cell interventions.

PubMed Disclaimer

Comment in

References

    1. Abou-El-Enein M., Bauer G., Reinke P., Renner M., Schneider C.K. A roadmap toward clinical translation of genetically-modified stem cells for treatment of HIV. Trends Mol. Med. 2014;20:632–642. - PubMed
    1. Abou-El-Enein M., Bauer G., Reinke P. Gene therapy: a possible future standard for HIV care. Trends Biotechnol. 2015;33:374–376. - PubMed
    1. Abou-El-Enein M., Elsanhoury A., Reinke P. Overcoming challenges facing advanced therapies in the EU market. Cell Stem Cell. 2016;19:293–297. - PubMed
    1. Alliance for Regenerative Medicine 2020: Growth and resilience in regenerative medicine annual report. 2021. http://alliancerm.org/wp-content/uploads/2021/03/ARM_AR2020_FINAL-PDF.pdf
    1. Bauer G., Elsallab M., Abou-El-Enein M. Concise review: a comprehensive analysis of reported adverse events in patients receiving unproven stem cell-based interventions. Stem Cells Transl. Med. 2018;7:676–685. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources